Physician

Vikram Singh Nijjar, MD

According to 2025 Medicare claims, Vikram Nijjar, MD (NPI: 1033298047) practices cardiology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is CENLA HEART SPECIALISTS LLC (NPI: 1063579456; TIN: 721270358) and primary practice location at 71301-3944. Nijjar is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Nijjar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,329 traditional Medicare patients, billed 4,378 HCPCS/CPT codes, and received $366,268 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 5,414 prescription claims across 726 beneficiaries totaling $325,672 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 28 claims. Open Payments data shows 9 records totaling $160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $7,226 to $2,339.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,803	7,443	$509,614
2016	1,965	19,560	$697,487
2017	2,105	23,815	$928,129
2018	2,052	10,506	$814,809
2019	2,113	9,265	$823,326
2020	1,887	6,669	$579,915
2021	1,955	6,659	$583,751
2022	1,745	5,819	$593,396
2023	1,628	5,019	$485,095
2024	1,329	4,378	$366,268

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	739	9,387	$272,734
2016	776	9,610	$281,795
2017	775	9,277	$280,531
2018	847	8,353	$269,359
2019	812	7,582	$274,479
2020	775	7,207	$297,304
2021	773	6,940	$296,223
2022	751	6,119	$315,701
2023	700	5,337	$341,361
2024	726	5,414	$325,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	75	$4,560
2016	N/R	182	$11,577
2017	N/R	184	$12,073
2018	N/R	100	$4,690
2019	N/R	19	$1,265
2020	N/R	55	$3,084
2021	N/R	55	$3,087
2022	N/R	28	$1,830
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	186	186	$303
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	641	648	$123
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	180	181	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	494	514	$82
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	187	188	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	222	8,205	$156,212
Xarelto	Rivaroxaban	91	3,870	$65,673
Brilinta	Ticagrelor	32	1,440	$20,844
Entresto	Sacubitril/Valsartan	15	360	$7,880
Clopidogrel	Clopidogrel Bisulfate	743	49,484	$6,705

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$160	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vikram Singh Nijjar, MD?

Tedicare shows public-source Medicare data for Vikram Singh Nijjar, MD (NPI 1033298047), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vikram Singh Nijjar, MD have ACO affiliation data?

Vikram Singh Nijjar, MD is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Vikram Singh Nijjar, MD?

Vikram Singh Nijjar, MD is linked to CENLA HEART SPECIALISTS LLC (billing NPI 1063579456) in the available physician profile data.

Does Vikram Singh Nijjar, MD have Open Payments data?

Vikram Singh Nijjar, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.